Am J Transplant, Volume 19, Suppl 3 Archives - Page 15 of 214 - ATC Abstracts

2019 American Transplant Congress
MELD-Na Alterations on the Liver Transplant Waiting List and Its Impact on Listing Outcome
G. Silberhumer¹, G. Gyoeri¹, L. Baumann¹, S. Zehetmayer², T. Soliman¹, G. Berlakovich¹
¹Transplant Surgery, Medical University Vienna, Vienna, Austria, ²Statistics Department, Medical University Vienna, Vienna, Austria
*Purpose: Currently, MELD Score listing is state of the art for liver transplant recipients. Our department could show by our own data and confirmed by…
2019 American Transplant Congress
Impact of Enteric Vancomycin Resistant Enterococcus Colonization on Waitlist Outcomes among Liver Transplant Candidates
E. Aldag, R. Pedersen, V. Gunabushanam, A. Sahajpal, T. J. Dilworth
Aurora St Luke's Medical Center, Milwaukee, WI
*Purpose: To determine the impact of Vancomycin Resistant Enterococcus (VRE) colonization on 90-day Liver Transplant (LT) waitlist outcomes.*Methods: Single center, retrospective observational study of LT…
2019 American Transplant Congress
Repeat Liver Transplantation after Failed First Transplant in Childhood: Development of a Retransplant Risk Index
M. Gupta¹, M. Barry², M. Levine³, K. Olthoff³, A. Shaked³, P. Abt³
¹University of Kentucky, Lexington, KY, ²University of California, San Francisco, San Francisco, CA, ³University of Pennsylvania, Philadelphia, PA
*Purpose: Most morbidity and mortality after pediatric liver retransplantation (LRTx) occurs in the first 100 days. We studied factors associated with mortality and graft failure…
2019 American Transplant Congress
The Impact Of Early Statin Use Following Lung Transplantation On The Development Of Bronchiolitis Obliterans Syndrome
B. Lindner¹, S. Strout¹, P. Shah²
¹Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD, ²Department of Pulmonology, The Johns Hopkins Hospital, Baltimore, MD
*Purpose: Conflicting data exists on the effect of statin therapy on the development of bronchiolitis obliterans syndrome (BOS) following lung transplantation, and limited literature is…
2019 American Transplant Congress
Anti-Fungal Prophylaxis in Lung Transplant: A Systematic Review/Meta-Analysis
K. Pennington, M. Baqir, P. Erwin, H. Murad, R. Razonable, C. C. Kennedy
Mayo Clinic, Rochester, MN
*Purpose: Invasive fungal infections (IFI) increase morbidity and mortality after lung transplant. Despite this, anti-fungal prophylaxis (AFP) in lung transplant recipients (LTR) varies by prophylactic…
2019 American Transplant Congress
Panniculectomy at the Time of Living Donor Renal Transplantation: An Eight Year Experience
L. M. Ngaage¹, A. Elegbede², K. K. Tasidina¹, S. Gebran³, E. Rada¹, A. J. Nam³, J. R. Scalea⁴, S. Niederhaus⁴, D. Singh¹, J. S. Bromberg⁴, S. T. Bartlett⁴, Y. M. Rasko¹
¹Department of Plastic Surgery, University of Maryland Medical Center, Baltimore, MD, ²Department of Plastic & Reconstructive Surgery, Johns Hopkins Hospital / University of Maryland Medical Center, Baltimore, MD, ³Division of Plastic & Reconstructive Surgery, R Adams Cowley Shock Trauma Center, Baltimore, MD, ⁴Department of Transplant Surgery, University of Maryland Medical Center, Baltimore, MD
*Purpose: Removal of the pannus, or panniculectomy, can be performed as a prophylactic procedure preceding renal transplantation to enable obese patients to meet criteria for…
2019 American Transplant Congress
The Medical Intensive Liver Unit: A Novel Multi-disciplinary Program For The Intensive Care Of Patients With Advanced Liver Disease
C. C. Lindenmeyer¹, G. Flocco¹, A. Sobotka¹, L. Kokoczka², B. Dolan², C. Strauser², C. Romero-Marrero¹, E. Mireles-Cabodevila², H. Khouli², C. Quintini³, A. Kapoor²
¹Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, OH, ²Department of Critical Care Medicine, Cleveland Clinic, Cleveland, OH, ³Transplantation Center, Cleveland Clinic, Cleveland, OH
*Purpose: Patients with advanced liver disease, particularly those with acute decompensation or acute liver failure (ALF) requiring intensive care unit (ICU) admission, are at elevated…
2019 American Transplant Congress
Beyond Medication Education: Opportunities for Improvement in Health Education of Solid Organ Transplant Recipients
Y. J. Bababekov, Y. Hsu, C. G. Rickert, Y. Hung, J. A. Fishman, J. F. Markmann, L. Dageforde, D. C. Chang, H. Yeh
Department of Surgery, Massachusetts General Hospital, Boston, MA
*Purpose: As immunosuppressive medications are crucial to graft and patient survival, transplant centers dedicate significant resources to medication education. However, patient outcomes also depend on…
2019 American Transplant Congress
International Multicenter Study Evaluating Clinical Outcomes Associated with Acute Antibody-Mediated Rejection
S. Corman¹, I. Hirji², E. Brouwer², S. H. Park¹, C. Macahilig³, A. Vergani², T. Bo², P. Wolthoff³, P. Keown⁴
¹Pharmerit International, Bethesda, MD, ²Shire, Cambridge, MA, ³Medical Data Analytics, Parsippany, NJ, ⁴University of British Columbia, Vancouver, BC, Canada
*Purpose: Evaluating factors that impact clinical outcomes of patients with acute antibody-mediated rejection (aAMR) may help manage and improve outcomes following kidney transplant. The objective…
2019 American Transplant Congress
Immediate Post Reperfusion In Vivo Transcriptional Responses of Individual Human Renal Allograft Cell Populations to Circulating Anti-Angiotensin II Type I Receptor Antibody
C. M. Castro -Rojas¹, N. Salomonis², K. Chetal², R. R. Alloway³, E. Woodle³, D. A. Hildeman¹
¹Immunobiology, Cincinnati Children's Hospital, Cincinnati, OH, ²Biomedical Informatics, Cincinnati Children's Hospital, Cincinnati, OH, ³Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH
*Purpose: Pre-existing anti-angiotensin II type I receptor (AT1R) antibodies can be a significant driver of allograft rejection. Indeed, prior work has shown that AT1R antibodies…